The Glaucoma Treatment Spectrum: Meds, Sustained Delivery, and MIGS
CME Activity Pricing
ASCRS Member Price: FREE
Nonmember Price: FREE
ASCRS gratefully acknowledges the unrestricted educational grants received in support of this program from AbbVie, Glaukos, Mati Therapeutics, and Sight Sciences.
This program is designed as a compact review of key surgical and therapeutic glaucoma treatments. Faculty will explore the various considerations for MIGS, to include standalone and next-generation devices and provide the latest details on glaucoma medical therapy.
Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.
Duration: 60 minutes
Activity Expiration Date: December 31, 2023
|Leon W. Herndon, MD||Nathan Radcliffe, MD|
|Jacob Brubaker. MD||Sahar Bedrood, MD||Won Kim, MD||Thomas Patrianakos, DO|
Ophthalmologists attending this program should be able to:
- Compare and contrast the various MIGS approaches now and in the pipeline for Glaucoma treatment.
- Describe new and emerging options in glaucoma medical therapy.